These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22374714)

  • 1. A case study on the in silico absorption simulations of levothyroxine sodium immediate-release tablets.
    Kocic I; Homsek I; Dacevic M; Grbic S; Parojcic J; Vucicevic K; Prostran M; Miljkovic B
    Biopharm Drug Dispos; 2012 Apr; 33(3):146-59. PubMed ID: 22374714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Justification of biowaiver for carbamazepine, a low soluble high permeable compound, in solid dosage forms based on IVIVC and gastrointestinal simulation.
    Kovacević I; Parojcić J; Homsek I; Tubić-Grozdanis M; Langguth P
    Mol Pharm; 2009; 6(1):40-7. PubMed ID: 19248231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro-in vivo correlation for gliclazide immediate-release tablets based on mechanistic absorption simulation.
    Grbic S; Parojcic J; Ibric S; Djuric Z
    AAPS PharmSciTech; 2011 Mar; 12(1):165-71. PubMed ID: 21181508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir.
    Shono Y; Jantratid E; Dressman JB
    Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
    Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biowaiver extension for BCS class III drugs: the effect of dissolution rate on the bioequivalence of BCS class III immediate-release drugs predicted by computer simulation.
    Tsume Y; Amidon GL
    Mol Pharm; 2010 Aug; 7(4):1235-43. PubMed ID: 20557130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro--in silico--in vivo drug absorption model development based on mechanistic gastrointestinal simulation and artificial neural networks: nifedipine osmotic release tablets case study.
    Ilić M; Ðuriš J; Kovačević I; Ibrić S; Parojčić J
    Eur J Pharm Sci; 2014 Oct; 62():212-8. PubMed ID: 24911992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
    Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
    Wei H; Löbenberg R
    Eur J Pharm Sci; 2006 Sep; 29(1):45-52. PubMed ID: 16815694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple level C in vitro/in vivo correlation of dissolution profiles of two L-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism.
    Volpato NM; Silva RL; Brito AP; Gonçalves JC; Vaisman M; Noël F
    Eur J Pharm Sci; 2004 Apr; 21(5):655-60. PubMed ID: 15066666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro-in-silico-in-vivo approach.
    Otsuka K; Wagner C; Selen A; Dressman J
    J Pharm Pharmacol; 2015 May; 67(5):651-65. PubMed ID: 25644429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling biopharmaceutical deciding properties of absorption of lansoprazole enteric-coated tablets using gastrointestinal simulation technology.
    Wu C; Sun L; Sun J; Yang Y; Ren C; Ai X; Lian H; He Z
    Int J Pharm; 2013 Sep; 453(2):300-6. PubMed ID: 23806811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro-in vivo-in silico approach in biopharmaceutical characterization of ibuprofen IR and SR tablets.
    Beloica S; Cvijić S; Bogataj M; Parojčić J
    Eur J Pharm Sci; 2015 Jul; 75():151-9. PubMed ID: 25861718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form.
    Souliman S; Blanquet S; Beyssac E; Cardot JM
    Eur J Pharm Sci; 2006 Jan; 27(1):72-9. PubMed ID: 16169713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining in vitro and in silico methods for better prediction of surfactant effects on the absorption of poorly water soluble drugs-a fenofibrate case example.
    Berthelsen R; Sjögren E; Jacobsen J; Kristensen J; Holm R; Abrahamsson B; Müllertz A
    Int J Pharm; 2014 Oct; 473(1-2):356-65. PubMed ID: 24997410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro--in silico--in vivo approach in biopharmaceutical drug characterization: metformin hydrochloride IR tablets.
    Beloica S; Cvijić S; Homšek I; Bogataj M; Parojčić J
    Pharmazie; 2015 Jul; 70(7):458-65. PubMed ID: 26373206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study in normal human volunteers to compare the rate and extent of levothyroxine absorption from Synthroid and Levoxine.
    Berg JA; Mayor GH
    J Clin Pharmacol; 1992 Dec; 32(12):1135-40. PubMed ID: 1487553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
    Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.